Suppr超能文献

碳离子放疗局部复发鼻咽癌患者的临床疗效。

Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.

机构信息

Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, China.

Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, China.

出版信息

Cancer. 2020 Dec 1;126(23):5173-5183. doi: 10.1002/cncr.33197. Epub 2020 Sep 15.

Abstract

BACKGROUND

Reirradiation for locoregionally recurrent nasopharyngeal carcinoma (LR-NPC) after high-dose radiotherapy (RT) is challenging and usually is associated with poor survival and severe toxicities. Because of its physical and biological advantages over photon-beam RT, carbon-ion RT (CIRT) could be a potential treatment option for patients with LR-NPC.

METHODS

Patients with LR-NPC who underwent salvage therapy using CIRT at the Shanghai Proton and Heavy Ion Center between May 2015 and June 2019 were analyzed. CIRT doses were 50 to 69 gray equivalent (GyE) (2.0-3.0 GyE per fraction). Overall survival (OS), local control, regional control, distant control, and acute and late toxicities were analyzed. Univariable and multivariable analyses of OS and local control were performed using the Cox regression model.

RESULTS

Among the 206 patients included, 139 patients (67.5%) had recurrent American Joint Committee on Cancer stage III or stage IV disease. With a median follow-up of 22.8 months, the 2-year OS, local control, regional control, and distant control rates were 83.7%, 58.0%, 87.3%, and 94.7%, respectively. Multivariable analysis revealed that older age (P = .017) was predictive of worse OS, whereas a larger tumor volume (P = .049) and a lower biological equivalent dose (P = .029) were associated with inferior local control. No patient developed an acute toxicity of ≥grade 3 during CIRT. Severe (≥grade 3) late toxicities included temporal lobe necrosis (0.97%), cranial neuropathy (0.49%), hearing loss (1.46%), xerostomia (0.49%), and mucosal necrosis (16.02%) (toxicities were graded using the Radiation Therapy Oncology Group and European Organization for Research and Treatment of Cancer criteria).

CONCLUSIONS

Salvage treatment using CIRT is efficacious for patients with LR-NPC and its toxicities are acceptable. CIRT may improve the survival and toxicity profiles substantially for patients with LR-NPC compared with the reported results after photon-based intensity-modulated RT.

摘要

背景

高剂量放疗(RT)后局部区域复发性鼻咽癌(LR-NPC)的再放疗具有挑战性,通常与生存不良和严重毒性相关。由于碳离子 RT(CIRT)在物理和生物学方面优于光子束 RT,因此 CIRT 可能是 LR-NPC 患者的潜在治疗选择。

方法

分析了 2015 年 5 月至 2019 年 6 月期间在上海质子重离子中心接受挽救性 CIRT 治疗的 LR-NPC 患者。CIRT 剂量为 50 至 69 格雷等效(GyE)(2.0-3.0GyE/次)。分析总生存期(OS)、局部控制、区域控制、远处控制以及急性和晚期毒性。采用 Cox 回归模型对 OS 和局部控制进行单变量和多变量分析。

结果

在 206 例患者中,139 例(67.5%)患者患有复发性美国癌症联合委员会(AJCC)第 III 期或第 IV 期疾病。中位随访 22.8 个月后,2 年 OS、局部控制、区域控制和远处控制率分别为 83.7%、58.0%、87.3%和 94.7%。多变量分析显示,年龄较大(P=0.017)与 OS 较差相关,而肿瘤体积较大(P=0.049)和生物等效剂量较低(P=0.029)与局部控制较差相关。在 CIRT 期间没有患者发生≥3 级急性毒性。严重(≥3 级)晚期毒性包括颞叶坏死(0.97%)、颅神经病变(0.49%)、听力损失(1.46%)、口干(0.49%)和黏膜坏死(16.02%)(根据放射治疗肿瘤学组和欧洲癌症研究与治疗组织标准进行分级)。

结论

LR-NPC 患者使用 CIRT 进行挽救性治疗是有效的,其毒性是可以接受的。与光子调强 RT 报道的结果相比,CIRT 可能显著改善 LR-NPC 患者的生存和毒性特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebb3/7693227/31080910e297/CNCR-126-5173-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验